Orakl Oncology

Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.

Health and bio

TIMELINE · MONEY RAISED

Orakl Oncology | 1136 days on the record

@orakldotbio·Raised $49M in 3 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. November 12, 2026
   Series A · $34M
   NNorrsken VC (lead), SSingular (lead)
   Source: sifted.eu
2. December 3, 2024
   Seed · $11.56M
   SSingular (lead), BBpifrance, HHCVC, SSistaFund, SSpeedinvest, VVerve Ventures
   Source: tech.eu
3. October 4, 2023
   Seed · $3.15M
   SSpeedinvest (lead), HHCVC, VVerve Ventures
   Source: benzinga.com

Founders and team

• DP
  Diane-Laure Pagès Founder
• FJ
  Fanny Jaulin Founder
• GR
  Gustave Ronteix Founder

Investors

• AAmazon Web Services (AWS)
• BBpifrance
• HHCVC
• NNorrsken VClead investor
• SSingularlead investor
• SSistaFund
• SSpeedinvestlead investor
• VVerve Ventures

Companies like Orakl Oncology

• EEpignostixSeed · Jul 2024
• BBIOMAKERSSeries A · Jul 2026
• OOncoPrecision
• TTubulis$360M Series B+ · Oct 2025
• VVelosbioSeries B+ · Aug 2026
• AAbTx$1.95M Seed · Sep 2026

Other companies backed by Norrsken VC

• 11KOMMA5°$78M Series B+ · Oct 2026
• VVocca$20M Series A · Oct 2026
• VVerse$54M Series B+ · Jun 2026
• BBiorce$52.5M Series A · Feb 2026
• Ttrawa$27M Series A · May 2025
• RRenaissance Fusion$37.62M Series A · Mar 2025

Norrsken VC portfolio →